<span style="font-family:Verdana;">The subjects of this study were to observe the improved short-term effects of anti-tumor purified Chinese medicine injection Ai-Jing for 138 cases with malignant tumo...<span style="font-family:Verdana;">The subjects of this study were to observe the improved short-term effects of anti-tumor purified Chinese medicine injection Ai-Jing for 138 cases with malignant tumors. This was a multi-center clinical study, and a total of 138 patients include</span><span style="font-family:Verdana;">d</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> 96 males and 42 females, with the age from 60 to 76 years. </span><span style="font-family:Verdana;">Ai-Jing has obtained the Chinese invention patent since 2008</span><span style="font-family:Verdana;"> (ZL991-03528.3). A novel technique acupoint injection method was adopted. Except for lung cancer, patients with other malignant tumors were injected once every other day, 2</span></span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">ml each time. A course of treatment needs 6 Ai-Jing injections, lung cancer patients need 10</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">-</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">20 Ai-Jing injections. At the same time, patients were treated with traditional medicine decoction. Due to the limited number of cases, cure rate, recovery rate and remission rate were calculated as a whole, respectively</span><span style="font-family:;" "=""> </span><span style="font-family:;" "=""><span style="font-family:Verdana;">18.12%, 44.20% and 32.15%. All the invalid patients were lung cancer, accounting for 16.67% of the patients treated with lung cancer, and the total treatment inefficiency was 6.52%. Conclusion: Chinese Medicine Injection Ai-Jing extracts the effective components of anti-cancer and tumorig</span><span style="font-family:Verdana;">enesis, and has the effects of anti-cancer and tumorigenesis, anti-infl</span><span style="font-family:Verdana;">am</span></span><span style="font-family:Verdana;">-</span><span style="font-family:Verdana;">matory and analgesic, and repairing body damage, with small toxic and side effects and low cost.</span>展开更多
OBJECTIVE: To investigate the curative effects of Xuebijing(XBJ) injection, a Chinese patent medicine, on severe pulmonary contusion(PC). METHODS: Sixty-three patients with PC were randomized to conventional therapy p...OBJECTIVE: To investigate the curative effects of Xuebijing(XBJ) injection, a Chinese patent medicine, on severe pulmonary contusion(PC). METHODS: Sixty-three patients with PC were randomized to conventional therapy plus XBJ injection(n=33) or conventional therapy alone(n=30). Between groups differences in corticosteroid treatment, immune regulation therapy, hemofiltration, infusion volume, transfusion volume and antibiotic period were measured, as were intensive care unit (ICU)-free time, ventilation time, 28-day mortality rate and incidence of ventilation-associated pneumonia(VAP). Serum concentrations of procalcitonin(PCT), tumor necrosis factor-α(TNF-α), interleukin(IL)-6, and IL-10, white blood cell(WBC) counts and percentages of human leukocyte antigen DR/ CD14+(HLA-DR/CD14+) peripheral blood mononuclear cells were compared. Markers of ventilation were determined by blood gas analysis and ventilator parameters. RESULTS: WBC counts and serum concentrations of PCT, TNF-α, IL-6 and IL-10 were reduced significantly more quickly, and CD14+ percentage was increased significantly earlier, in the XBJ group than in the control group(P<0.05 each).The level of ventilation and oxygenation index were ameliorated earlier in the XBJ than in the control group(P< 0.05). XBJ treatment significantly reduced ICU-stay time, ventilation time and incidence of VAP(P<0.05 each), but had no effect on 28-day mortality rate(P>0.05). CONCLUSION: XBJ treatment can shorten ICU-free and ventilation times and reduce the incidence of VAP, improving outcomes in patients with severe PC. XBJ may act by regulating inflammation and immunity, alleviating systemic inflammatory response syndrome induced by trauma.展开更多
目的:探讨依达拉奉治疗急性脑出血患者的临床疗效。方法:2013年2月-2014年4月收治急性脑出血患者126例,随机分成对照组和观察组,各63例,对照组按照降颅压、止血、抗感染和维持水电解质平衡治疗原则,给予醒脑静注射液20 m L+5%葡萄糖注射...目的:探讨依达拉奉治疗急性脑出血患者的临床疗效。方法:2013年2月-2014年4月收治急性脑出血患者126例,随机分成对照组和观察组,各63例,对照组按照降颅压、止血、抗感染和维持水电解质平衡治疗原则,给予醒脑静注射液20 m L+5%葡萄糖注射液250 m L,静滴,糖尿病患者用0.9%氯化钠注射液静滴;观察组在对照组的基础上给予依达拉奉注射液30 mg+0.9%氯化钠注射液静滴。两组均连续治疗21 d。结果:观察组基本痊愈19例,显著进步29例,进步12例,无效2例,死亡1例,总有效率95.2%;对照组基本痊愈15例,显著进步23例,进步11例,无效13例,死亡1例,总有效率77.8%,两组比较差异有统计学意义(P<0.05)。观察组治疗前NIHSS评分(11.2±1.8)分,治疗后(3.4±0.6)分,对照组治疗前NIHSS评分(11.2±1.7)分,治疗后(5.3±0.9)分,两组治疗前后比较差异有统计学意义(P<0.05),两组治疗后比较差异有统计学意义(P<0.05)。结论:依达拉奉治疗急性脑出血患者疗效显著,值得推广。展开更多
文摘<span style="font-family:Verdana;">The subjects of this study were to observe the improved short-term effects of anti-tumor purified Chinese medicine injection Ai-Jing for 138 cases with malignant tumors. This was a multi-center clinical study, and a total of 138 patients include</span><span style="font-family:Verdana;">d</span><span style="font-family:;" "=""><span style="font-family:Verdana;"> 96 males and 42 females, with the age from 60 to 76 years. </span><span style="font-family:Verdana;">Ai-Jing has obtained the Chinese invention patent since 2008</span><span style="font-family:Verdana;"> (ZL991-03528.3). A novel technique acupoint injection method was adopted. Except for lung cancer, patients with other malignant tumors were injected once every other day, 2</span></span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">ml each time. A course of treatment needs 6 Ai-Jing injections, lung cancer patients need 10</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">-</span><span style="font-family:;" "=""> </span><span style="font-family:Verdana;">20 Ai-Jing injections. At the same time, patients were treated with traditional medicine decoction. Due to the limited number of cases, cure rate, recovery rate and remission rate were calculated as a whole, respectively</span><span style="font-family:;" "=""> </span><span style="font-family:;" "=""><span style="font-family:Verdana;">18.12%, 44.20% and 32.15%. All the invalid patients were lung cancer, accounting for 16.67% of the patients treated with lung cancer, and the total treatment inefficiency was 6.52%. Conclusion: Chinese Medicine Injection Ai-Jing extracts the effective components of anti-cancer and tumorig</span><span style="font-family:Verdana;">enesis, and has the effects of anti-cancer and tumorigenesis, anti-infl</span><span style="font-family:Verdana;">am</span></span><span style="font-family:Verdana;">-</span><span style="font-family:Verdana;">matory and analgesic, and repairing body damage, with small toxic and side effects and low cost.</span>
基金Supported by grants from the National Natural Science Foundation of China(No.81101406)and(No.81071529)Project of Medical Research of PLA BWS12J108
文摘OBJECTIVE: To investigate the curative effects of Xuebijing(XBJ) injection, a Chinese patent medicine, on severe pulmonary contusion(PC). METHODS: Sixty-three patients with PC were randomized to conventional therapy plus XBJ injection(n=33) or conventional therapy alone(n=30). Between groups differences in corticosteroid treatment, immune regulation therapy, hemofiltration, infusion volume, transfusion volume and antibiotic period were measured, as were intensive care unit (ICU)-free time, ventilation time, 28-day mortality rate and incidence of ventilation-associated pneumonia(VAP). Serum concentrations of procalcitonin(PCT), tumor necrosis factor-α(TNF-α), interleukin(IL)-6, and IL-10, white blood cell(WBC) counts and percentages of human leukocyte antigen DR/ CD14+(HLA-DR/CD14+) peripheral blood mononuclear cells were compared. Markers of ventilation were determined by blood gas analysis and ventilator parameters. RESULTS: WBC counts and serum concentrations of PCT, TNF-α, IL-6 and IL-10 were reduced significantly more quickly, and CD14+ percentage was increased significantly earlier, in the XBJ group than in the control group(P<0.05 each).The level of ventilation and oxygenation index were ameliorated earlier in the XBJ than in the control group(P< 0.05). XBJ treatment significantly reduced ICU-stay time, ventilation time and incidence of VAP(P<0.05 each), but had no effect on 28-day mortality rate(P>0.05). CONCLUSION: XBJ treatment can shorten ICU-free and ventilation times and reduce the incidence of VAP, improving outcomes in patients with severe PC. XBJ may act by regulating inflammation and immunity, alleviating systemic inflammatory response syndrome induced by trauma.
文摘目的:探讨依达拉奉治疗急性脑出血患者的临床疗效。方法:2013年2月-2014年4月收治急性脑出血患者126例,随机分成对照组和观察组,各63例,对照组按照降颅压、止血、抗感染和维持水电解质平衡治疗原则,给予醒脑静注射液20 m L+5%葡萄糖注射液250 m L,静滴,糖尿病患者用0.9%氯化钠注射液静滴;观察组在对照组的基础上给予依达拉奉注射液30 mg+0.9%氯化钠注射液静滴。两组均连续治疗21 d。结果:观察组基本痊愈19例,显著进步29例,进步12例,无效2例,死亡1例,总有效率95.2%;对照组基本痊愈15例,显著进步23例,进步11例,无效13例,死亡1例,总有效率77.8%,两组比较差异有统计学意义(P<0.05)。观察组治疗前NIHSS评分(11.2±1.8)分,治疗后(3.4±0.6)分,对照组治疗前NIHSS评分(11.2±1.7)分,治疗后(5.3±0.9)分,两组治疗前后比较差异有统计学意义(P<0.05),两组治疗后比较差异有统计学意义(P<0.05)。结论:依达拉奉治疗急性脑出血患者疗效显著,值得推广。
